aluates Reports

$ 0.0

Automative

Global Nonalcoholic Steatohepatitis Diagnostic Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-17P14170

Global Nonalcoholic Steatohepatitis Diagnostic Market Research Report 2023

BUY CHAPTERS

Global Nonalcoholic Steatohepatitis Diagnostic Market Research Report 2025

Code: QYRE-Auto-17P14170

Report

May 2025

Pages:80

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Echosens

Prometheus Laboratories

Genfit SA

Siemens Medical Solutions USA, Inc

Quest Diagnostics Incorporated

Meridian Bioscience Inc.

Laboratory Corporation of America Holdings

BioPredictive S.A.S

Nonalcoholic Steatohepatitis Diagnostic Market Size

The global market for Nonalcoholic Steatohepatitis Diagnostic was valued at US$ 1571 million in the year 2024 and is projected to reach a revised size of US$ 2243 million by 2031, growing at a CAGR of 5.3% during the forecast period.

Nonalcoholic Steatohepatitis Diagnostic Market

Nonalcoholic steatohepatitis (NASH) is liver inflammation and damage caused by a buildup of fat in the liver. It is part of a group of conditions called nonalcoholic fatty liver disease.

The nonalcoholic steatohepatitis (NASH) diagnostic market is driven by the increasing prevalence of NASH and the growing awareness of the disease among healthcare providers and patients. NASH is a severe form of nonalcoholic fatty liver disease (NAFLD) characterized by liver inflammation and fibrosis, and it poses a significant global health burden. The rise in obesity rates, sedentary lifestyles, and unhealthy dietary habits contribute to the growing prevalence of NASH. Additionally, advancements in diagnostic technologies, such as non-invasive imaging techniques and blood biomarker assays, have improved early detection and accurate diagnosis of NASH. However, the market also faces challenges, including the lack of specific and validated diagnostic biomarkers for NASH, as well as the need for additional research and clinical validation to establish standardized diagnostic criteria. Moreover, the complex pathophysiology of NASH requires a multi-modal approach to diagnosis, making the development of comprehensive and cost-effective diagnostic strategies a challenge. To succeed in this market, companies must invest in research and development to identify reliable diagnostic biomarkers, collaborate with healthcare providers to improve disease awareness and diagnosis rates, and work towards developing integrated diagnostic algorithms to enhance NASH diagnosis and patient management.

This report aims to provide a comprehensive presentation of the global market for Nonalcoholic Steatohepatitis Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nonalcoholic Steatohepatitis Diagnostic.

The Nonalcoholic Steatohepatitis Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nonalcoholic Steatohepatitis Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nonalcoholic Steatohepatitis Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Nonalcoholic Steatohepatitis Diagnostic Market Report

Report Metric	Details
Report Name	Nonalcoholic Steatohepatitis Diagnostic Market
Accounted market size in year	US$ 1571 million
Forecasted market size in 2031	US$ 2243 million
CAGR	5.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Serum Biomarkers Hepatic Fibrosis Biomarkers Oxidative Stress Biomarkers Apoptosis Biomarkers Others
Segment by Application	Pharma & CRO Industry Hospitals Academic Research Institutes Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Echosens, Prometheus Laboratories, GENFIT SA, Siemens Medical Solutions USA, Inc., BioPredictive S.A.S, Quest Diagnostics Incorporated., Meridian Bioscience, Inc., Laboratory Corporation of America Holdings
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nonalcoholic Steatohepatitis Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Nonalcoholic Steatohepatitis Diagnostic Market growing?

Ans: The Nonalcoholic Steatohepatitis Diagnostic Market witnessing a CAGR of 5.3% during the forecast period 2025-2031.

What is the Nonalcoholic Steatohepatitis Diagnostic Market size in 2031?

Ans: The Nonalcoholic Steatohepatitis Diagnostic Market size in 2031 will be US$ 2243 million.

Who are the main players in the Nonalcoholic Steatohepatitis Diagnostic Market report?

Ans: The main players in the Nonalcoholic Steatohepatitis Diagnostic Market are Echosens, Prometheus Laboratories, GENFIT SA, Siemens Medical Solutions USA, Inc., BioPredictive S.A.S, Quest Diagnostics Incorporated., Meridian Bioscience, Inc., Laboratory Corporation of America Holdings

What are the Application segmentation covered in the Nonalcoholic Steatohepatitis Diagnostic Market report?

Ans: The Applications covered in the Nonalcoholic Steatohepatitis Diagnostic Market report are Pharma & CRO Industry, Hospitals, Academic Research Institutes, Others

What are the Type segmentation covered in the Nonalcoholic Steatohepatitis Diagnostic Market report?

Ans: The Types covered in the Nonalcoholic Steatohepatitis Diagnostic Market report are Serum Biomarkers, Hepatic Fibrosis Biomarkers, Oxidative Stress Biomarkers, Apoptosis Biomarkers, Others

Recommended Reports

Liver Disease Diagnostics

Liver Disease Therapeutics

Metabolic and Related Disorders

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nonalcoholic Steatohepatitis Diagnostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Serum Biomarkers

1.2.3 Hepatic Fibrosis Biomarkers

1.2.4 Oxidative Stress Biomarkers

1.2.5 Apoptosis Biomarkers

1.2.6 Others

1.3 Market by Application

1.3.1 Global Nonalcoholic Steatohepatitis Diagnostic Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharma & CRO Industry

1.3.3 Hospitals

1.3.4 Academic Research Institutes

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Nonalcoholic Steatohepatitis Diagnostic Market Perspective (2020-2031)

2.2 Global Nonalcoholic Steatohepatitis Diagnostic Growth Trends by Region

2.2.1 Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Nonalcoholic Steatohepatitis Diagnostic Historic Market Size by Region (2020-2025)

2.2.3 Nonalcoholic Steatohepatitis Diagnostic Forecasted Market Size by Region (2026-2031)

2.3 Nonalcoholic Steatohepatitis Diagnostic Market Dynamics

2.3.1 Nonalcoholic Steatohepatitis Diagnostic Industry Trends

2.3.2 Nonalcoholic Steatohepatitis Diagnostic Market Drivers

2.3.3 Nonalcoholic Steatohepatitis Diagnostic Market Challenges

2.3.4 Nonalcoholic Steatohepatitis Diagnostic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Nonalcoholic Steatohepatitis Diagnostic Players by Revenue

3.1.1 Global Top Nonalcoholic Steatohepatitis Diagnostic Players by Revenue (2020-2025)

3.1.2 Global Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share by Players (2020-2025)

3.2 Global Nonalcoholic Steatohepatitis Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Nonalcoholic Steatohepatitis Diagnostic Revenue

3.4 Global Nonalcoholic Steatohepatitis Diagnostic Market Concentration Ratio

3.4.1 Global Nonalcoholic Steatohepatitis Diagnostic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nonalcoholic Steatohepatitis Diagnostic Revenue in 2024

3.5 Global Key Players of Nonalcoholic Steatohepatitis Diagnostic Head office and Area Served

3.6 Global Key Players of Nonalcoholic Steatohepatitis Diagnostic, Product and Application

3.7 Global Key Players of Nonalcoholic Steatohepatitis Diagnostic, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Nonalcoholic Steatohepatitis Diagnostic Breakdown Data by Type

4.1 Global Nonalcoholic Steatohepatitis Diagnostic Historic Market Size by Type (2020-2025)

4.2 Global Nonalcoholic Steatohepatitis Diagnostic Forecasted Market Size by Type (2026-2031)

5 Nonalcoholic Steatohepatitis Diagnostic Breakdown Data by Application

5.1 Global Nonalcoholic Steatohepatitis Diagnostic Historic Market Size by Application (2020-2025)

5.2 Global Nonalcoholic Steatohepatitis Diagnostic Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Nonalcoholic Steatohepatitis Diagnostic Market Size (2020-2031)

6.2 North America Nonalcoholic Steatohepatitis Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2020-2025)

6.4 North America Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Nonalcoholic Steatohepatitis Diagnostic Market Size (2020-2031)

7.2 Europe Nonalcoholic Steatohepatitis Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2020-2025)

7.4 Europe Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size (2020-2031)

8.2 Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size by Region (2020-2025)

8.4 Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Nonalcoholic Steatohepatitis Diagnostic Market Size (2020-2031)

9.2 Latin America Nonalcoholic Steatohepatitis Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2020-2025)

9.4 Latin America Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size (2020-2031)

10.2 Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2020-2025)

10.4 Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Echosens

11.1.1 Echosens Company Details

11.1.2 Echosens Business Overview

11.1.3 Echosens Nonalcoholic Steatohepatitis Diagnostic Introduction

11.1.4 Echosens Revenue in Nonalcoholic Steatohepatitis Diagnostic Business (2020-2025)

11.1.5 Echosens Recent Development

11.2 Prometheus Laboratories

11.2.1 Prometheus Laboratories Company Details

11.2.2 Prometheus Laboratories Business Overview

11.2.3 Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic Introduction

11.2.4 Prometheus Laboratories Revenue in Nonalcoholic Steatohepatitis Diagnostic Business (2020-2025)

11.2.5 Prometheus Laboratories Recent Development

11.3 GENFIT SA

11.3.1 GENFIT SA Company Details

11.3.2 GENFIT SA Business Overview

11.3.3 GENFIT SA Nonalcoholic Steatohepatitis Diagnostic Introduction

11.3.4 GENFIT SA Revenue in Nonalcoholic Steatohepatitis Diagnostic Business (2020-2025)

11.3.5 GENFIT SA Recent Development

11.4 Siemens Medical Solutions USA, Inc.

11.4.1 Siemens Medical Solutions USA, Inc. Company Details

11.4.2 Siemens Medical Solutions USA, Inc. Business Overview

11.4.3 Siemens Medical Solutions USA, Inc. Nonalcoholic Steatohepatitis Diagnostic Introduction

11.4.4 Siemens Medical Solutions USA, Inc. Revenue in Nonalcoholic Steatohepatitis Diagnostic Business (2020-2025)

11.4.5 Siemens Medical Solutions USA, Inc. Recent Development

11.5 BioPredictive S.A.S

11.5.1 BioPredictive S.A.S Company Details

11.5.2 BioPredictive S.A.S Business Overview

11.5.3 BioPredictive S.A.S Nonalcoholic Steatohepatitis Diagnostic Introduction

11.5.4 BioPredictive S.A.S Revenue in Nonalcoholic Steatohepatitis Diagnostic Business (2020-2025)

11.5.5 BioPredictive S.A.S Recent Development

11.6 Quest Diagnostics Incorporated.

11.6.1 Quest Diagnostics Incorporated. Company Details

11.6.2 Quest Diagnostics Incorporated. Business Overview

11.6.3 Quest Diagnostics Incorporated. Nonalcoholic Steatohepatitis Diagnostic Introduction

11.6.4 Quest Diagnostics Incorporated. Revenue in Nonalcoholic Steatohepatitis Diagnostic Business (2020-2025)

11.6.5 Quest Diagnostics Incorporated. Recent Development

11.7 Meridian Bioscience, Inc.

11.7.1 Meridian Bioscience, Inc. Company Details

11.7.2 Meridian Bioscience, Inc. Business Overview

11.7.3 Meridian Bioscience, Inc. Nonalcoholic Steatohepatitis Diagnostic Introduction

11.7.4 Meridian Bioscience, Inc. Revenue in Nonalcoholic Steatohepatitis Diagnostic Business (2020-2025)

11.7.5 Meridian Bioscience, Inc. Recent Development

11.8 Laboratory Corporation of America Holdings

11.8.1 Laboratory Corporation of America Holdings Company Details

11.8.2 Laboratory Corporation of America Holdings Business Overview

11.8.3 Laboratory Corporation of America Holdings Nonalcoholic Steatohepatitis Diagnostic Introduction

11.8.4 Laboratory Corporation of America Holdings Revenue in Nonalcoholic Steatohepatitis Diagnostic Business (2020-2025)

11.8.5 Laboratory Corporation of America Holdings Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Echosens

Prometheus Laboratories

Genfit SA

Siemens Medical Solutions USA, Inc

Quest Diagnostics Incorporated

Meridian Bioscience Inc.

Laboratory Corporation of America Holdings

BioPredictive S.A.S

List of Tables

Table 1. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Serum Biomarkers

Table 3. Key Players of Hepatic Fibrosis Biomarkers

Table 4. Key Players of Oxidative Stress Biomarkers

Table 5. Key Players of Apoptosis Biomarkers

Table 6. Key Players of Others

Table 7. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Nonalcoholic Steatohepatitis Diagnostic Market Share by Region (2020-2025)

Table 11. Global Nonalcoholic Steatohepatitis Diagnostic Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Nonalcoholic Steatohepatitis Diagnostic Market Share by Region (2026-2031)

Table 13. Nonalcoholic Steatohepatitis Diagnostic Market Trends

Table 14. Nonalcoholic Steatohepatitis Diagnostic Market Drivers

Table 15. Nonalcoholic Steatohepatitis Diagnostic Market Challenges

Table 16. Nonalcoholic Steatohepatitis Diagnostic Market Restraints

Table 17. Global Nonalcoholic Steatohepatitis Diagnostic Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Nonalcoholic Steatohepatitis Diagnostic Market Share by Players (2020-2025)

Table 19. Global Top Nonalcoholic Steatohepatitis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonalcoholic Steatohepatitis Diagnostic as of 2024)

Table 20. Ranking of Global Top Nonalcoholic Steatohepatitis Diagnostic Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Nonalcoholic Steatohepatitis Diagnostic Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Nonalcoholic Steatohepatitis Diagnostic, Headquarters and Area Served

Table 23. Global Key Players of Nonalcoholic Steatohepatitis Diagnostic, Product and Application

Table 24. Global Key Players of Nonalcoholic Steatohepatitis Diagnostic, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share by Type (2020-2025)

Table 28. Global Nonalcoholic Steatohepatitis Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share by Type (2026-2031)

Table 30. Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share by Application (2020-2025)

Table 32. Global Nonalcoholic Steatohepatitis Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share by Application (2026-2031)

Table 34. North America Nonalcoholic Steatohepatitis Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Nonalcoholic Steatohepatitis Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size by Country (2026-2031) & (US$ Million)

Table 49. Echosens Company Details

Table 50. Echosens Business Overview

Table 51. Echosens Nonalcoholic Steatohepatitis Diagnostic Product

Table 52. Echosens Revenue in Nonalcoholic Steatohepatitis Diagnostic Business (2020-2025) & (US$ Million)

Table 53. Echosens Recent Development

Table 54. Prometheus Laboratories Company Details

Table 55. Prometheus Laboratories Business Overview

Table 56. Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic Product

Table 57. Prometheus Laboratories Revenue in Nonalcoholic Steatohepatitis Diagnostic Business (2020-2025) & (US$ Million)

Table 58. Prometheus Laboratories Recent Development

Table 59. GENFIT SA Company Details

Table 60. GENFIT SA Business Overview

Table 61. GENFIT SA Nonalcoholic Steatohepatitis Diagnostic Product

Table 62. GENFIT SA Revenue in Nonalcoholic Steatohepatitis Diagnostic Business (2020-2025) & (US$ Million)

Table 63. GENFIT SA Recent Development

Table 64. Siemens Medical Solutions USA, Inc. Company Details

Table 65. Siemens Medical Solutions USA, Inc. Business Overview

Table 66. Siemens Medical Solutions USA, Inc. Nonalcoholic Steatohepatitis Diagnostic Product

Table 67. Siemens Medical Solutions USA, Inc. Revenue in Nonalcoholic Steatohepatitis Diagnostic Business (2020-2025) & (US$ Million)

Table 68. Siemens Medical Solutions USA, Inc. Recent Development

Table 69. BioPredictive S.A.S Company Details

Table 70. BioPredictive S.A.S Business Overview

Table 71. BioPredictive S.A.S Nonalcoholic Steatohepatitis Diagnostic Product

Table 72. BioPredictive S.A.S Revenue in Nonalcoholic Steatohepatitis Diagnostic Business (2020-2025) & (US$ Million)

Table 73. BioPredictive S.A.S Recent Development

Table 74. Quest Diagnostics Incorporated. Company Details

Table 75. Quest Diagnostics Incorporated. Business Overview

Table 76. Quest Diagnostics Incorporated. Nonalcoholic Steatohepatitis Diagnostic Product

Table 77. Quest Diagnostics Incorporated. Revenue in Nonalcoholic Steatohepatitis Diagnostic Business (2020-2025) & (US$ Million)

Table 78. Quest Diagnostics Incorporated. Recent Development

Table 79. Meridian Bioscience, Inc. Company Details

Table 80. Meridian Bioscience, Inc. Business Overview

Table 81. Meridian Bioscience, Inc. Nonalcoholic Steatohepatitis Diagnostic Product

Table 82. Meridian Bioscience, Inc. Revenue in Nonalcoholic Steatohepatitis Diagnostic Business (2020-2025) & (US$ Million)

Table 83. Meridian Bioscience, Inc. Recent Development

Table 84. Laboratory Corporation of America Holdings Company Details

Table 85. Laboratory Corporation of America Holdings Business Overview

Table 86. Laboratory Corporation of America Holdings Nonalcoholic Steatohepatitis Diagnostic Product

Table 87. Laboratory Corporation of America Holdings Revenue in Nonalcoholic Steatohepatitis Diagnostic Business (2020-2025) & (US$ Million)

Table 88. Laboratory Corporation of America Holdings Recent Development

Table 89. Research Programs/Design for This Report

Table 90. Key Data Information from Secondary Sources

Table 91. Key Data Information from Primary Sources

Table 92. Authors List of This Report

List of Figures

Figure 1. Nonalcoholic Steatohepatitis Diagnostic Picture

Figure 2. Global Nonalcoholic Steatohepatitis Diagnostic Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Nonalcoholic Steatohepatitis Diagnostic Market Share by Type: 2024 VS 2031

Figure 4. Serum Biomarkers Features

Figure 5. Hepatic Fibrosis Biomarkers Features

Figure 6. Oxidative Stress Biomarkers Features

Figure 7. Apoptosis Biomarkers Features

Figure 8. Others Features

Figure 9. Global Nonalcoholic Steatohepatitis Diagnostic Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Nonalcoholic Steatohepatitis Diagnostic Market Share by Application: 2024 VS 2031

Figure 11. Pharma & CRO Industry Case Studies

Figure 12. Hospitals Case Studies

Figure 13. Academic Research Institutes Case Studies

Figure 14. Others Case Studies

Figure 15. Nonalcoholic Steatohepatitis Diagnostic Report Years Considered

Figure 16. Global Nonalcoholic Steatohepatitis Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Nonalcoholic Steatohepatitis Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Nonalcoholic Steatohepatitis Diagnostic Market Share by Region: 2024 VS 2031

Figure 19. Global Nonalcoholic Steatohepatitis Diagnostic Market Share by Players in 2024

Figure 20. Global Top Nonalcoholic Steatohepatitis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonalcoholic Steatohepatitis Diagnostic as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Nonalcoholic Steatohepatitis Diagnostic Revenue in 2024

Figure 22. North America Nonalcoholic Steatohepatitis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Nonalcoholic Steatohepatitis Diagnostic Market Share by Country (2020-2031)

Figure 24. United States Nonalcoholic Steatohepatitis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Nonalcoholic Steatohepatitis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Nonalcoholic Steatohepatitis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Nonalcoholic Steatohepatitis Diagnostic Market Share by Country (2020-2031)

Figure 28. Germany Nonalcoholic Steatohepatitis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Nonalcoholic Steatohepatitis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Nonalcoholic Steatohepatitis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Nonalcoholic Steatohepatitis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Nonalcoholic Steatohepatitis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Nonalcoholic Steatohepatitis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Nonalcoholic Steatohepatitis Diagnostic Market Share by Region (2020-2031)

Figure 36. China Nonalcoholic Steatohepatitis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Nonalcoholic Steatohepatitis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Nonalcoholic Steatohepatitis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Nonalcoholic Steatohepatitis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Nonalcoholic Steatohepatitis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Nonalcoholic Steatohepatitis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Nonalcoholic Steatohepatitis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Nonalcoholic Steatohepatitis Diagnostic Market Share by Country (2020-2031)

Figure 44. Mexico Nonalcoholic Steatohepatitis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Nonalcoholic Steatohepatitis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Nonalcoholic Steatohepatitis Diagnostic Market Share by Country (2020-2031)

Figure 48. Turkey Nonalcoholic Steatohepatitis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Nonalcoholic Steatohepatitis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Nonalcoholic Steatohepatitis Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Echosens Revenue Growth Rate in Nonalcoholic Steatohepatitis Diagnostic Business (2020-2025)

Figure 52. Prometheus Laboratories Revenue Growth Rate in Nonalcoholic Steatohepatitis Diagnostic Business (2020-2025)

Figure 53. GENFIT SA Revenue Growth Rate in Nonalcoholic Steatohepatitis Diagnostic Business (2020-2025)

Figure 54. Siemens Medical Solutions USA, Inc. Revenue Growth Rate in Nonalcoholic Steatohepatitis Diagnostic Business (2020-2025)

Figure 55. BioPredictive S.A.S Revenue Growth Rate in Nonalcoholic Steatohepatitis Diagnostic Business (2020-2025)

Figure 56. Quest Diagnostics Incorporated. Revenue Growth Rate in Nonalcoholic Steatohepatitis Diagnostic Business (2020-2025)

Figure 57. Meridian Bioscience, Inc. Revenue Growth Rate in Nonalcoholic Steatohepatitis Diagnostic Business (2020-2025)

Figure 58. Laboratory Corporation of America Holdings Revenue Growth Rate in Nonalcoholic Steatohepatitis Diagnostic Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Non Alcoholic Steatohepatitis NASH Therapeutics and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Alcoholic Steatohepatitis Therapeutics and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nonalcoholic Steatohepatitis NASH Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global NASH Non alcoholic Steatohepatitis Biomarkers Market Research Report 2024

Global Non Alcoholic Steatohepatitis Treatment Market Research Report 2025

Global Non Alcoholic Fatty Liver Disease Treatment Market Research Report 2024

Global Non alcoholic Steatohepatitis NASH Biomarkers Market Research Report 2024

Global Non Alcoholic Steatohepatitis NASH Treatment Market Insights Forecast to 2030

Nonalcoholic Steatohepatitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fatty Liver Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Alcoholic Steatohepatitis Biomarkers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Alcoholic Hepatitis Treatment Market Insights Forecast to 2030

Global Liver Cirrhosis Market Research Report 2024

Global Compensated Cirrhosis Type C Market Research Report 2024

Global Cardiac Cirrhosis Treatment Market Research Report 2024

Alcoholic Liver Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Liver Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lipid Metabolism Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Liver Fibrosis Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19Z7671

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10V14317

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10O5919

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4I19963

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions